|
|
 |
 |
 |
|
|
|||
|
||||
|
||||
Re: Oligohydramnios, dolicocephaly and elevated AFPFrom: Jim Wang (jimwangmd@yahoo.com)Thu Jun 23 11:11:28 2005
Dan, Once again, thank you for your sincere response. Yes, we will terminate Down's, trisomy 18 and trisomy 21. However, elevated AFAFP & AChE, if US continued to show normal anatomy and fetal movement, we will not choose to terminate. The reason I may seem "fixated" at a numeric risk estimate is that if the chance of having complications from amnio is, say 5%; but, the probability of finding chromosomal abnormality (maternal serum AFP screening is positive for spina bifida and negative for Downs, etc...) is say, 2% based on negative family history, etc... Then, we would deem the risk too high and decline amnio-infusion/centesis. If the estimated risk is even higher (say, 30%) and greatly exceeds the probability of finding a reason to terminate, such procedure- no matter how useful the information may be- is clearly an unfavorable gamble. This is why I feel quantifying the risks is important in making this difficult decision. Thanks. Regards, Jim Wang
At Thu, 23 Jun 2005, R. Daniel Braun wrote:
>
-- Jim Wang, MD
|
|
Return to
|
Mail a New Message to the Forum: ob-gyn-l@obgyn.net Forum Administrator: geffrey.klein@obgyn.net Report Technical Problems: webmaster@obgyn.net Last Updated: Tue Sep 2 05:04:05 2008 |
The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.